|
| ID |
DDInter1125 |
| Drug Type |
small molecule |
| Molecular Formula |
C29H41F2N5O |
| Molecular Weight |
513.677
|
| Description |
Maraviroc is a CCR5 co-receptor antagonist used with other antiretroviral medications to treat CCR5-tropic HIV-1 infection.
|
| ATC Classification |
J05AX09
|
| IUPAC Name |
4,4-Difluoro-N-[(1S)-3-[(1R,3S,5S)-3-[3-Methyl-5-(Propan-2-Yl)-4H-1,2,4-Triazol-4-Yl]-8-Azabicyclo[3.2.1]Octan-8-Yl]-1-Phenylpro |
| InChI |
Inchi=1S/C29H41F2N5O/C1-19(2)27-34-33-20(3)36(27)25-17-23-9-10-24(18-25)35(23)16-13-26(21-7-5-4-6-8-21)32-28(37)22-11-14-29(30,31)15-12-22/H4-8,19,22-26H,9-18H2,1-3H3,(H,32,37)/T23-,24+,25-,26-/M0/S1 |
| InChI Key |
GSNHKUDZZFZSJB-QYOOZWMWSA-N |
| Canonical SMILES |
CC(C)C1=NN=C(C)N1[C@H]1C[C@@H]2CC[C@H](C1)N2CC[C@H](NC(=O)C1CCC(F)(F)CC1)C1=CC=CC=C1 |
| Useful Links |
DrugBank
ChEMBL
PubChem
|